News
GRRMF
31.57
NaN%
--
Gerresheimer downgraded to Underweight from Equal Weight at Barclays
TipRanks · 04/28 08:35
Gerresheimer (0NTI) was downgraded to a Sell Rating at Barclays
TipRanks · 04/28 06:47
Midday Fly By: Netflix slumps as co-founder Hastings announces exit
TipRanks · 04/17 16:06
Gerresheimer rejects takeover bid from Silgan, Reuters reports
TipRanks · 04/17 11:17
Silgan Holdings: Strong Cash Flows Will Reduce Net Debt Fast
Seeking Alpha · 04/02 14:30
Silgan interested in Gerresheimer takeover - report
Seeking Alpha · 03/20 15:07
Bernstein Keeps Their Sell Rating on Gerresheimer (0NTI)
TipRanks · 03/16 12:26
Gerresheimer downgraded to Sell from Neutral at UBS
TipRanks · 02/23 19:10
ClearBridge International Value Strategy adds RHHBY and MKGAF; exits GRRMF, AKESF, and HKMPF
Seeking Alpha · 02/19 17:35
Diamond Hill International Strategy Q4 2025 Portfolio Review
Seeking Alpha · 02/17 07:14
Oakmark International Small Cap Strategy Q4 2025 Portfolio Drivers & Decisions
Seeking Alpha · 02/17 00:35
Deutsche Bank Keeps Their Hold Rating on Gerresheimer (0NTI)
TipRanks · 02/16 12:36
Berenberg Bank Remains a Hold on Gerresheimer (0NTI)
TipRanks · 02/16 07:05
DZ BANK AG Reaffirms Their Sell Rating on Gerresheimer (0NTI)
TipRanks · 02/13 04:55
Bernstein Remains a Sell on Gerresheimer (0NTI)
TipRanks · 02/12 14:56
Deutsche Bank Sticks to Their Hold Rating for Gerresheimer (0NTI)
TipRanks · 02/12 11:36
UBS Reaffirms Their Hold Rating on Gerresheimer (0NTI)
TipRanks · 02/11 14:25
Gerresheimer (0NTI) Gets a Buy from J.P. Morgan
TipRanks · 02/11 11:26
Gerresheimer (0NTI) Receives a Hold from Berenberg Bank
TipRanks · 01/23 11:56
Oakmark International Small Cap Fund: buys VISIF, exits GRRMF, JDEPF
Seeking Alpha · 01/20 10:39
More
Webull provides a variety of real-time GRRMF stock news. You can receive the latest news about Gerresheime through multiple platforms. This information may help you make smarter investment decisions.
About GRRMF
Gerresheimer AG is a Germany-based company that is active in the pharmaceuticals and health care industry. It operates through two business segments: Plastics and Devices, and Primary Packaging Glass. The Plastics and Devices segment produces standard and customized products for drug delivery, such as insulin pens, inhalers, and prefillable syrings. The Primary Packaging Glass segment focuses on the production of packaging of glass for medicines and cosmetics, such as pharmaceuticals jars, ampoules, injection vials, cartridges, perfume flacons and cream jars, as well as glass containers for the food and beverage industry. The Company operates approximately 40 production facilities in Europe, North America, South America and Asia.